The 12th CAR-TCR Summit brings together innovations in cell therapy development, engineering, and automation to advance the future of personalized treatments.
Key Topics
Automation strategies for manufacturing and quality control
New technologies for solid tumor targeting
Automation benefits and limitations in cell therapy
Novel cell types and armoring strategies for solid tumors
Cell therapy development from discovery to manufacturing
Successful outcomes in solid tumor therapies
Future directions with next-generation technologies
Automation implementation in personalized manufacturing
Pharma expectations for partnership opportunities
Tumor microenvironments and therapy penetration
Key outcomes in therapy success and failure
Engineering technologies for safety and reduced toxicity
